Keywords: Clinical trials, Industry influence, USA, R&D spending, Profit quest, PhRMA, Washington Post

PhRMA challenges Washington Post bias on clinical trials, research collaborations

Article | 27 November 2012

As drug industry’s influence over research grows, so does the potential for bias, according to a recent report ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in